Go
View All
Lack of engagement with psychological therapies
Lactate in blood, psychotropic agent effects
Legal issues
Less commonly used treatments, well supported by published evidence (no preference implied by order)
Leukopenia, psychotropic agent effects
Levetiracetam, for tardive dyskinesia
Libido
Licensed maximum doses of antipsychotics, according to US Food and Drug Administration labelling, where available
Linaclotide, for constipation treatment
Linear dose reductions of olanzapine cause increasingly large reductions in D2 dopaminergic receptor blockade.
Linear reductions of dose cause increasingly large reductions in effect on GABA-A receptor occupancy.
Linear reductions of dose cause increasingly large reductions in effect on receptor targets, probably associated with more withdrawal effects.
Lipoproteins in blood, psychotropic agent effects
Liraglutide, for antipsychotic-induced weight gain
Lithium: clinically relevant drug interactions
Lithium: prescribing and monitoring
Lithium plasma levels
Lithium use with
Lithium
Lofepidrine, in overdose
Lofexidine, clozapine-induced hypersalivation
Displaying items 1 - 30 of 44